Why Digital Health Has Not (Yet) Transformed Pharmaceutical Drug Development

While more have hailed the adoption of digital soundness by pharma, that’s not my fancy, at least on the R&D border. In my view, it remains very much on the “innovation initiative” border of things, rather than a perspicacious business need (like pharmacology); drug disclosure companies may be dipping their toes in and celebrating their boldness, but at best they are prejudiced – certainly not what I’d make appeal “pig committed.”

Vía Forbes Real Time http://ift.tt/1F6txPT

It’s a known deed that it is not necessary to dispose of on quality skin care products.

Both comments and pings are currently closed.